Evidence map›Paper›PMID 36510636›Full record

ArticleDrug delivery2023

Utilization of a nanostructured lipid carrier encapsulating pitavastatin-

Raed I Felimban, Hossam H Tayeb, Adeel G Chaudhary, Majed A Felemban, Fuad H Alnadwi, Sarah A Ali, Jazia A Alblowi, Eman ALfayez, Deena Bukhary, Mohammed Alissa and 1 more

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Innovative nanoparticle strategies for treating oral cancers.Medical oncology (Northwood, London, England) · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Raed I FelimbanDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Hossam H TayebDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Adeel G ChaudharyDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Majed A FelembanDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Fuad H AlnadwiDepartment of Nuclear Engineering, Faculty of Engineering, King Abdulaziz University, Jeddah, Saudi Arabia.
Sarah A AliDepartment of Oral Diagnostic Sciences, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Jazia A AlblowiDepartment of Periodontology Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Eman ALfayezDepartment of Oral Biology, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Deena BukharyDepartment of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Mohammed AlissaDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Safa H QahlDepartment of Biology, College of Science, University of Jeddah, Jeddah, Saudi Arabia.
King Abdulaziz University · SAJeddah University · SAPrince Sattam Bin Abdulaziz University · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is the most common epithelial tumor of the oral cavity. Gingival tumors, a unique type of OSCC, account for 10% of these malignant tumors. The antineoplastic properties of statins, including pitavastatin (PV), and the essential oil of the

Indexed as

Antineoplastic AgentsCarcinoma, Squamous CellGingival NeoplasmsMouth NeoplasmsNanostructuresPinusCell LineDrug CarriersDrug LiberationExcipientsFemaleHepatocyte Growth FactorHumansLipidsParticle SizeAntineoplastic AgentsDrug CarriersExcipientsHepatocyte Growth FactorHGF protein, humanLipidsexperimental designgingival cancernanostructured lipid carrierPinus densiflora leafPitavastatin

Identifiers

PMID36510636
PMCPMC9754020
OpenAlexW4311824259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.